Product Information
TIMOPTIC 0.5% OCUDOSE DROP is a brand product labeled by Bausch & Lomb Incorporated, priced at $10.3236 per EA under NDC 24208049968. Its NADAC has been published 178 times since May 10, 2023.
FDA first approved this application on Nov 5, 1986. Its Orange Book therapeutic-equivalence code is AT3.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6.8 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208049968
Classification
Brand
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA019463FDA Approved
11/5/1986
TE Code
AT3
On Market Since
2/17/2022
Pharmacological Classes
Price Statistics
The NADAC for TIMOPTIC 0.5% OCUDOSE DROP has been published 178 times since May 10, 2023, and over the history we have for it it has risen 8.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3236 per EA |
|---|---|
| All-time high | $10.3627 (May 14, 2025) |
| All-time low | $9.5494 (May 10, 2023) |
| 52-week high | $10.3236 |
| 52-week low | $10.2520 |
| Median price | $10.2301 |
| Average price | $10.1238 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 178 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOPTIC 0.5% OCUDOSE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOPTIC 0.5% OCUDOSE DROP, manufactured by Bausch & Lomb Incorporated, is $10.3236 per EA (NDC 24208049968), effective Sep 30, 2026.
How has the price of TIMOPTIC 0.5% OCUDOSE DROP changed over time?
Over the history we have for it, the NADAC for TIMOPTIC 0.5% OCUDOSE DROP has risen 8.1%. It has been tracked across 178 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for TIMOPTIC 0.5% OCUDOSE DROP?
Since May 10, 2023, the NADAC for TIMOPTIC 0.5% OCUDOSE DROP has ranged from a low of $9.5494 (May 10, 2023) to a high of $10.3627 (May 14, 2025), with a median of $10.2301 per EA.
Are there cheaper alternatives to TIMOPTIC 0.5% OCUDOSE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.5% EYE DROP, is $1.2555 per EA — about 88% below TIMOPTIC 0.5% OCUDOSE DROP.
Who manufactures TIMOPTIC 0.5% OCUDOSE DROP?
TIMOPTIC 0.5% OCUDOSE DROP (NDC 24208049968) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.